Dianthus Therapeutics, Inc.
DNTH NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 4, 2026
ET
EPS Est.
-0.85
EPS Actual
-0.90
Revenue Est.
$297182
Revenue Actual
$761000
Next Earnings Report Date unconfirmed
Date
Nov 4, 2026 · Wed
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
-1.02
Revenue Est.
$400833
Company Overview
Dianthus Therapeutics, Inc. (ticker DNTH) is listed on NASDAQ with a market cap of about $6.21B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of -1.02. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Nov 3, 2022 → Aug 4, 2026
Nov 3, 2022Range: -7.52 ~ -0.51Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | -0.85 | -0.90 | $297182 | $761000 |
| May 5, 2026 | -- | -1.17 | Above forecast↑-0.85 | $403615 | $463000 |
| Mar 9, 2026 | -- | -0.98 | Below forecast↓-1.43 | $552231 | $284000 |
| Nov 5, 2025 | -- | -0.86 | -0.97 | $576000 | $396000 |
| Aug 7, 2025 | -- | -0.86 | -0.88 | $858200 | $193000 |
| May 12, 2025 | -- | -0.86 | -0.82 | $806900 | $1.2M |
| Mar 11, 2025 | -- | -0.85 | -0.81 | $955222 | $1.3M |
| Nov 7, 2024 | -- | -0.59 | Below forecast↓-0.74 | $741143 | $2.2M |
| Aug 8, 2024 | -- | -0.55 | -0.51 | $368857 | $1.9M |
| May 9, 2024 | -- | -0.43 | Below forecast↓-0.54 | $464250 | $874000 |
| Mar 21, 2024 | -- | -1.11 | Above forecast↑-0.71 | $548500 | $457000 |
| Nov 9, 2023 | -- | -0.51 | Below forecast↓-3.78 | $250000 | $924000 |
| Aug 3, 2023 | -- | -0.80 | Below forecast↓-3.12 | -- | $1M |
| May 15, 2023 | -- | -6.40 | Below forecast↓-7.52 | -- | $476000 |
| Nov 3, 2022 | -- | -4.64 | -4.32 | -- | $1.2M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-04 ↗
Earnings Release8-K · 2026-08-04 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-05 ↗
Annual10-K · 2026-03-09 ↗
Earnings Release8-K · 2026-03-09 ↗
Quarterly10-Q · 2025-11-05 ↗
Earnings Release8-K · 2025-11-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
